Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros












Intervalo de año de publicación
1.
Circ Cardiovasc Interv ; 17(6): e013902, 2024 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-38583174

RESUMEN

BACKGROUND: Coronary slow flow (CSF) by invasive coronary angiography is frequently understood to be an indicator of coronary microvascular dysfunction (CMD) in patients with ischemia with nonobstructive coronary arteries. However, the relationship between visual estimates of CSF and quantitative wire-based invasive diagnosis of CMD is uncertain. METHODS: We prospectively enrolled adults aged ≥18 years with stable ischemic heart disease who were referred for invasive coronary angiography. Individuals with ≥50% epicardial coronary artery stenosis were excluded. Invasive coronary angiography was reviewed for CSF, defined as ≥3 cardiac cycles to opacify distal vessels with contrast. Coronary function testing was performed in the left anterior descending coronary artery using bolus coronary thermodilution techniques to measure coronary flow reserve (CFR) and the index of microcirculatory resistance (IMR). Invasively determined CMD was defined as abnormal CFR (<2.5), abnormal IMR (≥25), or both. RESULTS: Among 104 participants, the median age was 61.5 years and 79% were female. The median CFR was 3.6 (interquartile range, 2.5-4.7) and the median IMR was 21 (interquartile range, 13.3-28.0). Overall, 24.0% of participants had abnormal CFR, 34.6% had abnormal IMR, and 48.1% had a final diagnosis of invasively determined CMD. CSF was present in 23 participants (22.1%). The proportions of patients with CMD (56.5% versus 45.7%; P=0.36), abnormal CFR (17.4% versus 25.9%; P=0.40), and abnormal IMR (43.5% versus 32.1%; P=0.31) were not different in patients with versus without CSF. CONCLUSIONS: Among patients with ischemia with nonobstructive coronary artery, CSF was not associated with abnormal CFR, IMR, or either abnormal CFR or IMR. CSF is not a reliable angiographic surrogate of abnormal CFR or IMR as determined by invasive, wire-based physiology testing. REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT03537586.


Asunto(s)
Angiografía Coronaria , Enfermedad de la Arteria Coronaria , Circulación Coronaria , Vasos Coronarios , Microcirculación , Valor Predictivo de las Pruebas , Humanos , Femenino , Masculino , Persona de Mediana Edad , Anciano , Estudios Prospectivos , Vasos Coronarios/fisiopatología , Vasos Coronarios/diagnóstico por imagen , Enfermedad de la Arteria Coronaria/fisiopatología , Enfermedad de la Arteria Coronaria/diagnóstico por imagen , Enfermedad de la Arteria Coronaria/diagnóstico , Cateterismo Cardíaco , Reproducibilidad de los Resultados , Velocidad del Flujo Sanguíneo , Termodilución , Reserva del Flujo Fraccional Miocárdico , Resistencia Vascular
4.
Am J Cardiol ; 118(4): 477-81, 2016 Aug 15.
Artículo en Inglés | MEDLINE | ID: mdl-27328954

RESUMEN

Left transradial approach (TRA) for coronary angiography is associated with lower radiation parameters than right TRA in an all-comers population. The aim of this study was to determine the effects of left versus right TRA on radiation parameters in patients with predictors of TRA failure. Patients with predictors of TRA failure (≥3 of 4 following criteria: age ≥70 years, female gender, height ≤64 inches, and hypertension) referred to TRA operators were randomized to either right (n = 50) or left (n = 50) TRA, whereas those referred to transfemoral approach (TFA) operators were enrolled in a prospective registry (n = 50). The primary end point was the radiation measure of dose-area product (DAP). In an intention-to-treat analysis, DAP (34.1 Gy·cm(2) [24.9 to 45.6] vs 41.9 Gy·cm(2) [27.3 to 58.0], p = 0.08), fluoroscopy time (3.7 minutes [2.4 to 6.3] vs 5.6 minutes [3.1 to 8.7], p = 0.07), and operator radiation exposure (516 µR [275 to 967] vs 730 µR [503 to 1,165], p = 0.06) were not significantly different between left and right TRA, but total dose (411 mGy [310 to 592] vs 537 mGy [368 to 780], p = 0.03) was significantly lower with left versus right TRA. Radiation parameters were lowest in the TFA cohort (DAP 24.5 Gy·cm(2) [15.7 to 33.2], p <0.001; fluoroscopy time 2.3 minutes [1.5 to 3.7], p <0.001; operator radiation exposure 387 µR [264 to 557]; total dose 345 mGy [250 to 468], p = 0.001). Results were similar after adjustment for differences in baseline characteristics. In conclusion, median measurements of radiation were overall not significantly different between left versus right TRA in this select population of patients with predictors of TRA failure. All measurements of radiation were lowest in the TFA group.


Asunto(s)
Cateterismo Cardíaco/métodos , Angiografía Coronaria/métodos , Arteria Radial , Dosis de Radiación , Sistema de Registros , Factores de Edad , Anciano , Estatura , Cardiólogos , Femenino , Fluoroscopía , Humanos , Hipertensión/epidemiología , Masculino , Persona de Mediana Edad , Exposición Profesional , Factores Sexuales
5.
Bogota; s.n; feb. 1997. 65 p. tab, graf.
Tesis en Español | LILACS | ID: lil-190395

RESUMEN

En este estudio se quizo determinar las ventajas de la angioplastia primaria como tratamiento del infarto frente a la estreptoquinasa. Dada la disponibilidad del laboratorio de hemodinamia en la Fundación Santafé, y la posibilidad de realizar angioplastia primaria en pacientes con infarto del miocardio. Se tomaron pacientes con esta patología en grupos de casos y controles para comparar los beneficios de la Angioplastia en cuanto a disminución de morbimortalidad y una mejor función ventricular izquierda. Los resultados mostraron que la PTCA fué exitosa en el 61.9 por ciento de los casos y subóptima en 28.6 por ciento. La trombolisis fué clínicamente exitosa en 80 por ciento de los controles. No se encontraron diferencias significativas en cuanto a función ventricular izquierda, en los dos grupos. Concluimos que la PTCA en nuestra institución puede ser considerada un tratamiento alterno del infarto del miocardio con un buen porcentaje de éxito terapéutico y baja morbimortalidad.


Asunto(s)
Angioplastia Coronaria con Balón , Infarto del Miocardio
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...